Steve Miller - 20 Nov 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
20 Nov 2025
Transactions value $
$0
Form type
4
Filing time
24 Nov 2025, 20:08:36 UTC
Previous filing
28 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Miller Steve Chief Op. & Scientific Officer 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ Steve Miller 24 Nov 2025 0001402535

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise +8.27K +0.78% 1.07M 21 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +158K +12.19% $0.00 1.46M 20 Nov 2025 Common Stock 158K $22.77 Direct F2
transaction CPRX Restricted Stock Units Award $0 +47.8K +3.32% $0.00 1.49M 20 Nov 2025 Common Stock 47.8K Direct F2, F3
transaction CPRX Restricted Stock Units Options Exercise $0 -8.27K -0.55% $0.00 1.5M 21 Nov 2025 Common Stock 8.27K Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2 Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027, and 1/3rd on November 20, 2028.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.
F4 Derivative securities vest in three equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026, and 1/3rd on November 21, 2027.
F5 Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on November 21, 2025.